Inspire Medical Systems Inc (NYSE: INSP) stock fell -2.16% on Friday to $140.25 against a previous-day closing price of $143.34. With 0.66 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.76 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $146.28 whereas the lowest price it dropped to was $139.57. The 52-week range on INSP shows that it touched its highest point at $330.00 and its lowest point at $123.27 during that stretch. It currently has a 1-year price target of $212.67. Beta for the stock currently stands at 1.41.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of INSP was up-trending over the past week, with a rise of 11.58%, but this was down by -10.70% over a month. Three-month performance dropped to -35.73% while six-month performance fell -54.50%. The stock lost -34.97% in the past year, while it has lost -44.32% so far this year. A look at the trailing 12-month EPS for INSP yields -1.13 with Next year EPS estimates of -0.68. For the next quarter, that number is -0.22. This implies an EPS growth rate of 10.71% for this year and 52.24% for next year. EPS is expected to grow by 44.50% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -14.18%.
Float and Shares Shorts:
At present, 29.01 million INSP shares are outstanding with a float of 28.91 million shares on hand for trading. On Oct 30, 2023, short shares totaled 1.2 million, which was 4.05% higher than short shares on Sep 28, 2023. In addition to Mr. Timothy P. Herbert as the firm’s CEO, President & Director, Mr. Richard J. Buchholz serves as its Chief Financial Officer.
Through their ownership of 99.87% of INSP’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 57.09% of INSP, in contrast to 44.38% held by mutual funds. Shares owned by individuals account for 16.40%. As the largest shareholder in INSP with 11.04% of the stake, Fidelity Management & Research Co holds 3,237,401 shares worth 3,237,401. A second-largest stockholder of INSP, The Vanguard Group, Inc., holds 2,969,217 shares, controlling over 10.12% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in INSP, holding 1,401,917 shares or 4.78% stake. With a 3.14% stake in INSP, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 920,801 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 2.58% of INSP stock, is the second-largest Mutual Fund holder. It holds 756,650 shares valued at 111.35 million. Fidelity Select Medical Technolog holds 2.11% of the stake in INSP, owning 620,000 shares worth 91.24 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for INSP since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With INSP analysts setting a high price target of $250.00 and a low target of $150.00, the average target price over the next 12 months is $212.67. Based on these targets, INSP could surge 78.25% to reach the target high and rise by 6.95% to reach the target low. Reaching the average price target will result in a growth of 51.64% from current levels.
Summary of Insider Activity:
Insiders traded INSP stock several times over the past three months with 6 Buys and 3 Sells. In these transactions, 9,453 shares were bought while 99,208 shares were sold. The number of buy transactions has increased to 69 while that of sell transactions has risen to 74 over the past year. The total number of shares bought during that period was 104,404 while 217,336 shares were sold.